BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2814484
Number of visits today
33
Number of downloads
2064808
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Elrakaybi A, Laubner K, Zhou Q, Hug MJ, Seufert J. Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role? Mol Metab 2022;:101549. [PMID: 35863639 DOI: 10.1016/j.molmet.2022.101549] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Aragón-Herrera A, Moraña-Fernández S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, García-Seara J, Román A, Seijas J, García-Caballero L, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Lage R, Gualillo O, González-Juanatey JR, Feijóo-Bandín S, Lago F. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats. Biomed Pharmacother 2023;161:114535. [PMID: 36931025 DOI: 10.1016/j.biopha.2023.114535] [Reference Citation Analysis]
2 Tsai PC, Chuang WJ, Ko AM, Chen JS, Chiu CH, Chen CH, Yeh YH. Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trials. Cardiovasc Diabetol 2023;22:57. [PMID: 36915157 DOI: 10.1186/s12933-023-01789-5] [Reference Citation Analysis]
3 Pistelli L, Parisi F, Correale M, Cocuzza F, Campanella F, de Ferrari T, Crea P, De Sarro R, La Cognata O, Ceratti S, Recupero T, Ruocco G, Palazzuoli A, Imbalzano E, Dattilo G. Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy-A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure. J Clin Med 2023;12. [PMID: 36615178 DOI: 10.3390/jcm12010379] [Reference Citation Analysis]
4 Mistry N, Bakris GL. The changing trajectory of diabetic kidney disease. Curr Opin Nephrol Hypertens 2023;32:98-102. [PMID: 36250469 DOI: 10.1097/MNH.0000000000000844] [Reference Citation Analysis]
5 Packer M. How can sodium-glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron-deficient? Implications for understanding iron homeostasis in heart failure. Eur J Heart Fail 2022;24:2287-96. [PMID: 36377108 DOI: 10.1002/ejhf.2731] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345